Mizuho Issues Positive Forecast for Align Technology (NASDAQ:ALGN) Stock Price

Align Technology (NASDAQ:ALGN) had its price objective lifted by analysts at Mizuho from $200.00 to $215.00 in a research report issued to clients and investors on Thursday,MarketScreener reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. Mizuho’s price objective points to a potential upside of 21.31% from the stock’s current price.

Several other equities research analysts also recently commented on ALGN. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a report on Thursday, October 30th. Weiss Ratings raised shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, January 16th. Stifel Nicolaus increased their price target on shares of Align Technology from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Thursday. Piper Sandler boosted their price objective on shares of Align Technology from $200.00 to $220.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, Barclays began coverage on shares of Align Technology in a report on Monday, December 8th. They issued an “equal weight” rating and a $170.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $193.08.

Align Technology Trading Up 9.9%

Shares of NASDAQ ALGN traded up $15.93 during mid-day trading on Thursday, hitting $177.23. The company had a trading volume of 1,418,271 shares, compared to its average volume of 1,004,988. The company has a market capitalization of $12.72 billion, a PE ratio of 34.31, a price-to-earnings-growth ratio of 1.76 and a beta of 1.84. The firm has a 50-day simple moving average of $161.89 and a two-hundred day simple moving average of $148.59. Align Technology has a one year low of $122.00 and a one year high of $232.20.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.99 by $0.30. The business had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. Align Technology had a return on equity of 13.96% and a net margin of 9.50%.Align Technology’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.44 earnings per share. Sell-side analysts expect that Align Technology will post 7.98 earnings per share for the current fiscal year.

Institutional Trading of Align Technology

Hedge funds have recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Align Technology by 38.9% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 15,551 shares of the medical equipment provider’s stock worth $2,029,000 after buying an additional 4,359 shares in the last quarter. Hussman Strategic Advisors Inc. bought a new stake in Align Technology in the third quarter valued at $3,156,000. QRG Capital Management Inc. acquired a new position in shares of Align Technology during the second quarter valued at about $306,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Align Technology during the 3rd quarter worth about $1,327,000. Finally, Nordea Investment Management AB grew its stake in shares of Align Technology by 20.7% in the 3rd quarter. Nordea Investment Management AB now owns 770,360 shares of the medical equipment provider’s stock valued at $95,178,000 after buying an additional 132,019 shares during the period. 88.43% of the stock is owned by institutional investors and hedge funds.

Align Technology News Roundup

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q4 earnings and revenue beat — Align reported EPS of $3.29 vs. $2.99 consensus and revenue of $1.05B vs. $1.03B, driven by higher Clear Aligner volumes. Strong top- and bottom-line beats are the primary catalyst for the rally. Zacks: ALGN Stock Climbs on Q4
• Positive Sentiment: Record Invisalign/Clear Aligner volumes — Management highlighted record aligner volumes, a clear operational positive that supports revenue momentum and the bullish investor reaction. Benzinga: Invisalign Volumes Hit Records
• Positive Sentiment: Analyst upgrades and forecast increases — Multiple analysts raised forecasts and reiterated/initiated bullish views (including William Blair maintaining a Buy), supporting further upside expectations. Benzinga: Analysts Increase Forecasts
• Neutral Sentiment: Q1 revenue guidance roughly in line with Street — Management issued first-quarter revenue guidance near consensus (~$1.0B), which reduces near-term forecast risk but offers limited positive surprise. Reuters: Beats Q4; Guidance In Line
• Neutral Sentiment: 2026 revenue target and DSO momentum — Company outlined a 3%–4% revenue growth target for 2026 and emphasized DSO channel gains and digital initiatives; positive for longer term but not an immediate earnings kicker. Seeking Alpha: 2026 Outlook
• Neutral Sentiment: Options market activity noted — Commentary on options flow may indicate elevated short-term trading interest, but that can amplify both directions and is not a directional fundamental. Benzinga: Options Market
• Negative Sentiment: Margins contracted — Gross and operating margins fell in the quarter, which could pressure profitability if not reversed, and investors will watch margin recovery in 2026. Zacks: Margins Down
• Negative Sentiment: Morgan Stanley’s view is cautious despite raising the price target — MS lifted its PT to $169 (from $154) but kept an “equal weight” rating, implying limited near-term upside relative to the current trading level. Benzinga: Morgan Stanley PT
• Negative Sentiment: Short interest report appears inconsistent — a flagged increase in short interest lacks reliable figures in the data; ambiguous but worth monitoring if accurate increases occur. Short Interest Note

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.